These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 37099969)

  • 1. Metabolic-related gene signatures for survival prediction and immune cell subtypes associated with prognosis in intrahepatic cholangiocarcinoma.
    Jin Z; Liu YH
    Cancer Genet; 2023 Jun; 274-275():84-93. PubMed ID: 37099969
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Wu J; Guo Y; Zuo ZF; Zhu ZW; Han L
    World J Gastroenterol; 2023 May; 29(19):2961-2978. PubMed ID: 37274806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing metabolic gene signatures to predict intrahepatic cholangiocarcinoma prognosis and mining a miRNA regulatory network.
    Ran X; Luo J; Zuo C; Huang Y; Sui Y; Cen J; Tang S
    J Clin Lab Anal; 2022 Jan; 36(1):e24107. PubMed ID: 34871464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
    Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
    BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMLI-ICC: an ensemble machine learning-based integration algorithm for metastasis prediction and risk stratification in intrahepatic cholangiocarcinoma.
    Ruan J; Xu S; Chen R; Qu W; Li Q; Ye C; Wu W; Jiang Q; Yan F; Shen E; Chu Q; Jia Y; Zhang X; Fu W; Chen J; Timko MP; Zhao P; Fan L; Shen Y
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36259363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
    Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
    BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a new prognostic immune-inflammatory-nutritional score for predicting outcomes after curative resection for intrahepatic cholangiocarcinoma: A multicenter study.
    Zhu J; Wang D; Liu C; Huang R; Gao F; Feng X; Lan T; Li H; Wu H
    Front Immunol; 2023; 14():1165510. PubMed ID: 37063918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
    Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma.
    Sae-Fung A; Mutirangura A; Jitkaew S
    Front Immunol; 2022; 13():1051273. PubMed ID: 36733386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration and validation of a novel ferroptosis-related gene signature predicting the prognosis of intrahepatic cholangiocarcinoma.
    Yao X; Chen B; Wang M; Zhang S; He B; Shi Z; Deng T; Bao W; Wang Y; Chen G; Bo Z
    Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 54(9):1376-1385. PubMed ID: 36111744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma.
    Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
    World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
    Qin X; Song Y
    Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cholangiocarcinoma Prediction Model Based on Random Forest and Artificial Neural Network Algorithm.
    Liao J; Meng C; Liu B; Zheng M; Qin J
    J Coll Physicians Surg Pak; 2023 May; 33(5):578-586. PubMed ID: 37190696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative prediction of postsurgical outcomes in mass-forming intrahepatic cholangiocarcinoma based on clinical, radiologic, and radiomics features.
    Park HJ; Park B; Park SY; Choi SH; Rhee H; Park JH; Cho ES; Yeom SK; Park S; Park MS; Lee SS
    Eur Radiol; 2021 Nov; 31(11):8638-8648. PubMed ID: 33890153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a ferroptosis-related gene signature for predicting the prognosis of cholangiocarcinoma.
    Wang Z; Zhang Y; Chen Y; Liu S; Li C; Li X
    Expert Rev Gastroenterol Hepatol; 2022 Feb; 16(2):181-191. PubMed ID: 35026122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma.
    Shimada M; Sugimoto K; Iwahashi S; Utsunomiya T; Morine Y; Imura S; Ikemoto T
    J Gastroenterol; 2010 Aug; 45(8):896-902. PubMed ID: 20379837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of nomogram model in evaluating the prognosis of cholangiocarcinoma after interventional therapy].
    Li Z; Xie BC; Lyu PJ; Wang HX; Li Y; Wang CH; Li X; Ye SW; Li G; Pang PF; Zhang YY; Yu P
    Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1217-1224. PubMed ID: 37087405
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
    Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis.
    Shirabe K; Shimada M; Tsujita E; Aishima S; Maehara S; Tanaka S; Takenaka K; Maehara Y
    Am J Surg; 2004 Apr; 187(4):538-42. PubMed ID: 15041507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Prognostic Factors in Cholangiocarcinoma Based on Integrated ceRNA Network Analysis.
    Jin H; Liu W; Xu W; Zhou L; Luo H; Xu C; Chen X; Chen W
    Comput Math Methods Med; 2022; 2022():7102736. PubMed ID: 36158120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.